Sign in

NCT05143255Completed

Developing a Communication Intervention for People With Memory Challenges and Their Care Partners

Developing a Communication Intervention to Help People With Memory Challenges and Their Care Partners Engage in Advance Care Planning

Source: ClinicalTrials.gov · Last updated 25 Mar 2026

Brief summary (registry, in English)

The proposed research is consistent with broader public health goals focused on improving communication regarding end-of-life care and the Centers for Medicare and Medicaid Services' (CMS) call for increased patient engagement in advance care planning (ACP) as part of standard care. The proposed study will address this public health issue by developing a communication-based intervention designed to improve Alzheimer's Disease and Related Dementias (ADRD) patients' and care partners' engagement in ACP, distress and care partner burden, and completion of advance directives and receipt of goal-concordant care at the end-of-life. Therefore, this study is aligned with the National Institute on Aging's long-term goal to improve the quality of care for ADRD patients and CMS's goal to increase engagement in ACP.

Status (registry)
Completed
Study type
Interventional
Enrollment
38 (actual)
First submitted
18 Nov 2021
Start date
9 Dec 2024
Primary completion date
5 Feb 2026
Lead sponsor
Weill Medical College of Cornell University
NCT number
NCT05143255

What you commit to

  • Study type: Interventional
  • Participants enrolled: 38
  • From 9 Dec 2024 to the primary completion date, 5 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Below we outline criteria for patient/care recipient (CR) (which includes patient/CR only or patient/CR enrolled as part of a dyad), care partner (CR) (which includes CR only or CR enrolled as part of a dyad), and dyad only relevant eligibility criteria:
  • Patient/care recipient (CR) eligibility criteria:
  • Montreal Cognitive Assessment-Blind (MoCA-B) score of 9-18;
  • decision-making capacity to consent to a low risk study as indicated by a score of ≥9 on the University of California-San Diego Brief Assessment of Capacity to Consent, a 10-item measure validated in patients with challenges in memory;
  • capacity to execute a Health Care Proxy, as indicated by a score of ≥ 11 on the validated and reliable HCP Guidelines for ability to execute a HCP among nursing home residents;
  • age ≥ 65;
  • reports receiving care and/or support from an unpaid care partner; and
  • reports that at least one of their ADs has not been completed (for CR's enrolled without a CP only).
    • A MoCA-B score of 9-18 is consistent with clinical guidelines for an average MoCA score for individuals with mild Alzheimer's disease and is within the threshold for having capacity to complete advance directives. Patients with this score are mobile, communicative, and generally involved in making medical care decisions. While patients must report having a care partner to be eligible, the patient can be enrolled in the study even if their care partner is not enrolled.
    • Care partner (CP) eligibility criteria:
  • provides informal (unpaid) care for a person with memory challenges, per self-report;
  • MoCA-B score of ≥19; and reports that at least one of the CR's ADs has not been completed (for CPs enrolled without a patient only).
    • While care partners must report caring for a person with memory challenges, the care partner can be enrolled in the study even if the patient is not enrolled.
    • Eligibility criteria for CRs and CPs enrolled as a dyad: In addition to the criteria above for CR and CP: (1) the CR and/or CP report that at least one of the CR's ADs has not been completed.
    • Patient and care partner exclusion criteria:
  • not fluent in English;
  • ≤17 years of age;
  • too ill or weak to complete the interviews (per the interviewer);
  • presence of significant sensory, language, or motor deficit (e.g., visual or hearing loss, paralysis, aphasia) (per self report, the interviewer or medical record); or
  • patient is in the late stage of dementia (i.e., severe cognitive impairment), is bed-bound, or has a nursing home admission planned within 12 months per CP report or the medical record.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Weill Cornell Medicine
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.